Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 12.8 M12.39 M12.99 M12.69 M 50.87 M Research & development ———— — Operating income 76.97 M79.72 M86.01 M82.25 M 324.94 M Non-Operating Income, Total 18.47 M37.87 M34.04 M47.59 M 137.98 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 18.03 M37.83 M31.43 M48.22 M 135.51 M Unusual income/expense 447 K35 K2.61 M-629 K 2.47 M Pretax income 95.45 M117.58 M120.05 M129.84 M 462.92 M Equity in earnings 9.44 M20.07 M11.31 M11.11 M 51.92 M Taxes 18.38 M13.98 M27.25 M15.59 M 75.2 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 53.74 M70.89 M58.37 M66.17 M 249.18 M Discontinued operations ———— — Net income 53.74 M70.89 M58.37 M66.17 M 249.18 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 69.78 M92.53 M74.42 M66.17 M 302.91 M Basic earnings per share (Basic EPS) 1.31.711.39— — Diluted earnings per share (Diluted EPS) 1.281.71.371.21 5.56 Average basic shares outstanding 41.37 M41.44 M41.56 M41.61 M — Diluted shares outstanding 54.47 M54.48 M54.48 M54.47 M — EBITDA 79.5 M82.23 M88.43 M84.65 M 334.82 M EBIT 76.97 M79.72 M86.01 M82.25 M 324.94 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 2.53 M2.52 M2.43 M2.4 M 9.88 M